UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 28, 2005
BIOJECT MEDICAL TECHNOLOGIES INC.
(Exact name of registrant as specified in its charter)
Commission File Number: 0-15360
Oregon |
| 93-1099680 |
(State or other jurisdiction of incorporation |
| (I.R.S. Employer Identification No.) |
|
|
|
211 Somerville Road, Route 202 North, |
| 07921 |
(Address of principal executive offices) |
| (Zip Code) |
|
|
|
Registrant’s telephone number, including area code: (908) 470-2800 | ||
|
|
|
Former name or former address if changed since last report: no change |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
BIOJECT MEDICAL TECHNOLOGIES INC.
FORM 8-K
INDEX
Item |
| Description |
|
|
|
|
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
2
Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On March 28, 2005, Joseph R. Ianelli informed the President and Chief Executive Officer of Bioject Medical Technologies Inc. that he was going to resign as a director of the company. On March 30, 2005, Mr. Ianelli submitted his resignation as a director of the company effective immediately.
3
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: April 1, 2005 | BIOJECT MEDICAL TECHNOLOGIES INC. | |
| (Registrant) | |
|
| |
|
| |
| /s/ JOHN GANDOLFO |
|
| John Gandolfo | |
| Chief Financial Officer and Vice President of Finance |
4